Webinars are hour-long interactive programs discussing the diagnosis and treatment of specific lymphoma subtypes and key research and treatment updates. Webinars feature a presentation from the featured expert, with the remainder of the time allocated to an extensive Q&A session. Program Overview Current Role of Protein Inhibitors in Treating Lymphoma and CLL The Need for Protein Degraders How Protein Degraders Work Current Data and Response Rates in Lymphoma and CLL Side Effects of Protein Degraders Ongoing Trials and Future Applications Question and Answer Session